The European lactase persistence genotype determines the lactase persistence state and correlates with gastrointestinal symptoms in the Hispanic and Amerindian Chilean population: a case–control and population-based study by Morales, Eugenia et al.
The European lactase persistence
genotype determines the lactase
persistence state and correlates with
gastrointestinal symptoms in the
Hispanic and Amerindian Chilean
population: a caseecontrol and
population-based study
Eugenia Morales,
1 Lorena Azocar,
1 Ximena Maul,
2 Claudio Perez,
2 Jose ´ Chianale,
1
Juan Francisco Miquel
1
ABSTRACT
Background: The lactase persistent (LP) or lactase non-
persistent (LNP) state in European adults is genetically
determined by a single nucleotide polymorphism (SNP)
located 13.9 kb upstream of the lactase (LCT) gene,
known as LCT C>T 13910 (rs4988235). The LNP
condition leads to an inability to digest the milk sugar
lactose leading to gastrointestinal symptoms and can
affect nutrient and calcium intake in certain populations.
Objectives: The authors studied a group of 51 Chilean
patients to assess whether this SNP inﬂuences the LP/
LNP state in this population, and determined the
prevalence of LCT C>T 13910 genotypes in
a representative sample of 216 Hispanics and 43
Amerindians with correlation to digestive symptoms.
Design: Caseecontrol study done in Chilean patients
with clinical suspicion of LNP that were assessed
using clinical survey, hydrogen breath test (HBT) and
SNP genotyping. The population sample of Hispanics
and Amerindians was assessed by clinical survey and
SNP genotyping.
Results: Of the 51 patients with clinical suspicion of
LNP, 29 were HBT-positive. The CC genotype (LNP)
was present in 89.7% of the patients with positive HBT
and in only 4.7% of those with negative HBT. The
prevalence of the CC genotype was 56.9% in the
Hispanic population and 88.3% in Amerindians, and
was associated with a higher self-reported clinical
intolerance to ingestion of dairy products.
Conclusion: The LP/LNP state is determined by the
LCT C>T 13910 variant in Chileans. This variant
predicts digestive symptoms associated with the
ingestion of lactose and is a good tool for the
diagnosis of primary adult hypolactasia. The LCT
T 13910 allele is rare in the Amerindian population and
is suggestive of European ancestry in this
contemporary population.
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ARTICLE SUMMARY
Article focus
- The aims of the present study were three
questions; (1) to determine if the European
variant C/T-13910 determined the lactose-persis-
tent and lactose non-persistent state in the adult
Chilean Hispanic and Amerindian population; (2)
to determine if there is any correlation between
the C/T-13910 genotyping and the hydrogen
breath test for diagnosis of lactase non-persis-
tence in our population; (3) to determine for the
ﬁrst time in an Latin American population the
prevalence of the lactose non-persistence geno-
type (CC) and its correlation with digestive
symptoms and ingestion of dairy products.
Key messages
- We demonstrate for the ﬁrst time that the
European lactase persistence  13910T variant
determines lactase persistence in the Chilean
Hispanic and Amerindian population.
- We demonstrate a strong correlation between the
C-13910>T genotype with the hydrogen breath
test and lactose tolerance in a group of patients
with clinical suspicion of lactose intolerance.
- In a representative sample of the Hispanic
Chilean population (Mestizos) and in Amerin-
dians, we observed a high prevalence of the
lactose non-persistence genotype (CC) with
a clear gradient between ethnic groups (56%
and 88%, respectively). Interestingly, the C-
13910>T genotype was signiﬁcantly associated
with digestive symptoms and self-reporting
intolerance to ingestion of dairy products. This
could explain the observed low consumption of
dairy products (30 l milk/person/year) in our
population.
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Open Access ResearchINTRODUCTION
Lactose, the main sugar in milk, must be hydrolysed by
lactase-phlorizin hydrolase into glucose and galactose for
absorption. Intestinal activity of the lactase enzyme (LCT)
(MIM 603202) decreases in all mammals after weaning,
resulting in poor lactose absorption.
1 In humans, this
condition is termed ‘lactase non-persistence’ (LNP),
‘adult type hypolactasia’ (MIM 223100) and is estimated
to occur in approximately 65% of the contemporary
world population.
23LNP can generate intolerance to the
ingestion of dairy products with the development of
abdominal and systemic symptoms that lead to medical
consultations and evaluations. In contrast, lactase-persis-
tent (LP) individuals remain tolerant of lactose and
maintain high levels of LCT expression throughout
adult life.
4 The prevalence of the LP phenotype, which is
an autosomal dominant condition (MIM 223100), is
reported to vary between 0 and 95% in different
populations,
3 but is unknown in contemporary Latin
American populations.
25
The recent discovery of single nucleotide poly-
morphisms (SNPs) that determine the LP state in
humans, both in Europe
6 and among some pastoral
populations in Africa, has generated growing interest in
the study of this condition.
27The appearance of these
SNPs seems to have occurred on more than one occasion
in human evolution between 1500 and 12000 years ago
in northern Europe and among some nomadic popula-
tions of Asia and Africa.
7 The SNP known as LCT
C>T 13910 (rs4988235) is located 13.9 kb upstream of
the LCT gene in the 13th intron of an adjacent gene
(MCM6). The T allele of this SNP correlates with the LP
state in European populations,
6 and individuals with this
allele have higher levels of LCT transcripts in enterocytes
compared with individuals who carry the C allele.
8 In
vitro studies show that cells transfected with the LCT
T 13910 variant show increased activity of the LCT
promoter.
9 Another SNP known as LCT G>A 22018
shows some association with the LP/LNP phenotype,
and while it does not appear to be the causal variant, it is
present in a block of linkage disequilibrium with little
evidence of recombination in this region of the
genome.
51 0
In clinical practice, the LNP state is relevant because it
can generate malabsorption and intolerance of lactose,
with the development of clinical symptoms such as
abdominal pain and distension, diarrhoea, bloating,
nausea and vomiting.
3 A signiﬁcant percentage of
patients do not relate these symptoms to ingestion of
dairy products,
11 and the recurring nature of the symp-
toms can lead to misdiagnosis of chronic diarrhoea,
irritable bowel syndrome, celiac illness or other clinical
conditions.
12e16 The diagnosis of LNP is often based on
clinical suspicion and the favourable response to
a lactose-restricted diet.
The most widely used diagnostic test of poor lactose
absorption is the hydrogen breath test (HBT).
11 17
Nevertheless, this test has practical limits, and its sensi-
tivity and speciﬁcity vary between 69 and 100% and
between 89 and 100%, respectively, compared with
measurement of LCT activity in intestinal biopsies.
Additionally, there is a false-negative rate of 11e30% and
a false-positive rate of up to 57% using this test.
18e20
Using SNP genotyping in patients with suspected LNP
may therefore aid in proper diagnosis.
10 21e25 The only
epidemiological study of adult hypolactasia in a Chilean
population was performed more than three decades
ago
26 and suggested that the prevalence of LNP was 56%
and 75% for the paediatric and adult populations,
respectively. Our objectives were to determine the
inﬂuence of the LCT C>T 13910 SNP on the LP/LNP
state in the Chilean population and to determine the
population prevalence of the SNP genotypes in a repre-
sentative Hispanic and Amerindian population with
comparison of the genotypes to clinical symptoms
related to ingestion of dairy products.
SUBJECTS AND METHODS
Patients with clinical suspicion of LNP
In 2006, 51 patients were enrolled in a prospective study
after being referred to the Gastroenterological Depart-
ment of the Clinical Hospital at the Pontiﬁcia Univer-
sidad Catolica de Chile because of symptoms suggestive
of LNP. A precoded survey was obtained from all patients
to obtain demographic, anthropometric, familial and
clinical data, including any symptoms experienced
during the diagnostic HBT such as abdominal pain,
diarrhoea, bloating, nausea and vomiting. A 5 ml
Article summary
Strengths and limitations of this study
- This is the ﬁrst study in Latin America to assess whether the
European LP 13910T variant determines lactase persistence
in the Chilean Hispanic and Amerindian general population.
- Our results may be of clinical and epidemiological relevance,
not only for the Chilean population, but also for other Hispanic
and Amerindian populations of the Americas of a similar
genetic background. The fact that the lactase non-persistence
state is an inherited frequent condition in Mestizo and
Amerindians should be considered when developing public
programmes that encourage consumption of dairy products,
and should be a stimulus for the food industry to develop new
and high-quality lactose-free dairy products in these regions.
- We randomly selected a representative sample of the Hispanic
Chilean population (n¼216) and Amerindians (n¼43), and
performed the genotyping of LCT C>T 13910. We observed
a high prevalence of the lactose non-persistence genotype (CC)
with a clear gradient between both ethnic groups (56% and
88%, respectively) that correlates with digestive symptoms
and self-reporting intolerance to ingestion of dairy products.
- Non-randomised recruitment of the 51 patients with suspicion
of lactose intolerance could induce selection bias.
- A small number of patients with suspicion of lactose
intolerance (n¼51).
- Semiquantitative food-frequency questionnaire with a 24 h
dietary recall obtained in a subgroup of the Hispanics and
performed years before the genetic analysis.
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European lactase genotype determines lactase phenotype in Chilean populationethylenediaminetetraacetic acid blood sample was
obtained to extract DNA. Serum levels of immunoglob-
ulin A and tissue antitransglutaminase antibodies (hu
tTG ELISA, IMMCO Diagnostics, Buffalo, NY) were
quantiﬁed in all the patients to rule out the existence of
celiac disease. This study was approved by the Ethics
Committee of the Faculty of Medicine, Pontiﬁcia
Universidad Cato ´lica de Chile, and all patients signed
a written informed consent form prior to the study.
HBT for diagnosis of LNP
Patients were instructed to maintain a low-ﬁbre diet
without lactose for 48 h prior to the day of the exami-
nation. After 12 h of fasting, a baseline concentration
of H2 in exhaled breath was determined using a
Quintron microLyzer (QuinTron Instrument Company,
Milwaukee, Wisconsin). Subjects then ingested 25 g of
lactose, and the H2 concentration in breath was quanti-
ﬁed every 20 min for a maximum of 4 h. Individuals were
considered LNP with an increase in H2 concentration
20 ppm above the base value.
17 27
Population study
A representative sample of 216 unrelated Hispanics and
43 unrelated Amerindians were randomly selected from
an initial sample of 1581 Hispanics and 120 Amerindians
(Mapuches, the Chilean native population) which
were collected between 1993 and 2000 as described
previously.
28 29 By using an Amerindian Admixture
Index based on ABO blood-group distribution, we have
previously demonstrated in these cohorts a 40% and
80% Amerindian ancestry in the Hispanic and Mapuche
population, respectively. Furthermore, 88% of Hispanics
and 100% of Mapuches shared ancestral Amerindian
mtDNA polymorphism.
28 29 These results were in
accordance with the biparental founder origin of the
mixed Chilean population, which could be similar to
other Hispanic populations from America.
30e32
The sample size was selected by estimating an expected
prevalence of the LCT-13910CC genotype to be at least
50% in the Hispanic population and 80% in the Amer-
indians, with an a error of 5% and a level of conﬁdence
of 80%. All study subjects provided a DNA sample and
a medical survey that provided anthropometric and
clinical data including information about diarrhoea,
abdominal pain or bloating in response to ingestion of
dairy products.
28 29 Furthermore, a subgroup of the
Hispanic subjects provided a semiquantitative food-
frequency questionnaire with a 24 h dietary recall. From
these data, speciﬁc energy and nutrient ingestion from
dairy products was estimated using the Datadiet
programme.
28 33 For all subjects, the occurrences of
digestive symptoms in response to consumption of
lactose were correlated to SNP genotyping results.
Genotyping of LCT C>TL13910 and LCT G>AL22018 SNPs
SNP genotyping was performed using PCR-restriction
fragment length polymorphism (RFLP) methods
34
(GenBank reference sequence NM_005915.4). Brieﬂy,
genomic DNA was extracted from 300 ml of blood
according to the manufacturer’s instructions (Wizard SV
Genomic DNA Puriﬁcation System; Promega, Madison,
Wisconsin), and the regions surrounding the SNPs were
ampliﬁed through PCR using primers (F) 59-GGA TGC
ACT GCT GTG ATG AG-39 and (R) 5-CCC ACT GAC
CTA TCC TCG TG-39 for the LCT C>T 13910 and (F) 59-
AAC AGG CAC GTG GAG GAG TT-39 and (R) 59- CCC
ACC TCA GCC TCT TGA GT-39 for LCT G>A 22018.I n
both cases, the ampliﬁed products were of 448 bp. The
PCR reactions and RFLP assays for the analysis of both
genetic variants were carried out as described previ-
ously.
34 Brieﬂy, the ampliﬁed product for the LCT
C>T 13910 SNP was digested with BsmFI, generating two
fragments of 351 and 97 bp in the presence of the CC
genotype, and three fragments of 253, 98 and 97 bp in
the presence of the TT genotype (ﬁgure 1). For the LCT
G>A 22018 SNP, the PCR product was digested with
HhaI, generating two fragments of 284 and 184 bp in the
presence of the GG genotype and one undigested frag-
ment of 448 bp in the presence of the A/A genotype.
The ampliﬁed and digested PCR products were sepa-
rated by electrophoresis on 2% agar gels in 1X TAE
buffer stained with ethidium bromide. Genotyping
conﬁrmation was carried out on 35 samples by direct
sequencing of the 448 bp ampliﬁed fragments (models
Figure 1 Restriction fragment length polymorphism (RFLP)
and sequence analysis of a 448 bp region of MCM6 intron 13
containing the lactase (LCT) C>T 13910 single nucleotide
polymorphism. Upper panel: RFLP analysis of the 448 bp
amplicon digested with BsmFI. Left lane, 50 bp DNA ladder.
Right lane, undigested PCR amplicon. Centre lanes, digested
products from representative individuals having the three
different SNP genotypes. The ancestral LCT-13910CC
genotype results in two bands of 350 bp and 110 bp; the LCT-
13910CT genotype results in three bands of 350 bp, 240 bp
and 110 bp; the LCT-13910TT genotype results in two bands
of 240 bp and 110 bp. Lower panel: representative sequence
tracings showing conﬁrmation of RFLP data. A direct sequence
analysis was performed on 35 of the 51 samples.
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Applied Biosystems, Foster City, California) (ﬁgure 1).
There was complete concordance between the
PCR-RFLP analysis and the sequencing in all cases.
Statistical analysis
Means and standard deviations were used to describe
numeric variables. The variables of categorical types
were given as a number and a percentage. Comparisons
of continuous variables were performed using the
Student t test for independent samples. Comparisons of
categorical variables were carried out using the c
2 test.
Using the HBT breath test as diagnostic for LNP, an
analysis of the sensitivity and speciﬁcity of the genetic
test as an alternative diagnostic test was carried out.
Differences were considered signiﬁcant when p<0.05.
RESULTS
HBT and SNP genotyping
Fifty-one patients with clinical suspicion of LNP (44
women and 7 men, age 14e79 years) were included in
the study. Twenty-nine patients (56.8%) had a positive
HBT, and 22 were negative (43.2%) (table 1). There
were no signiﬁcant differences in the distribution by sex
and age between the two groups. There was a positive
correlation between the HBT results and digestive
symptoms reported during the test: 82% of the patients
with positive HBT had symptoms associated with the
lactose load, such as bloating, abdominal pain and
diarrhoea (79%, 58% and 20%, respectively). In
contrast, only 27% of the patients with negative HBT
presented symptoms after ingesting lactose (p<0.001).
Additionally, 76% of patients with positive HBT indi-
cated a personal and/or family history of functional
digestive disorders, compared with 36% of those with
negative HBT (p<0.001).
The LCTC>T 13910 SNP genotyping results for the 51
patients are shown in table 1. Of the 29 patients with
positive HBT, 26 (89.7%) had the LCT-13910CC geno-
type (the LNP genotype), and three (10.3%) had the
LCT-13910CT genotype and were therefore phenotypi-
cally LNP but genotypically LP. However, two of these
three patients experienced bloating and diarrhoea
during the HBT, which suggests malabsorption of
lactose. Of the 22 patients who had a negative HBT, 19
were LCT-13910CT, two were LCT-13910TT, and a single
16-year-old patient had the LNP LCT-13910CC genotype
(table 1). However, this patient experienced abdominal
pain during the HBT. Subsequent evaluation of this
patient with a lactulose HBT (10 g load) revealed that
this patient was not a non-producer of hydrogen. A
single patient with LNP genotype and positive HBT had
high levels of anti-tTG (27 EU/ml), which suggests the
possibility of coexistence of LNP and celiac disease. All
the patients showed normal levels of serum IgA (data
not shown).
There was a complete genotypic correlation between
the LCTC>T 13910 and the LCTG>A 22018 SNPs, such
that any subject homozygous or heterozygous for one
SNP was at the same time homozygous or heterozygous
for the other SNP (data not shown). Furthermore, there
was a good correlation between the LCTC>T 13910 SNP
ﬁndings and the HBT test results (table 2). Genotyping
results were conﬁrmed by sequencing for 35 of the 51
samples (ﬁgure 2). Interestingly, one of the three
discordant patients with LNP phenotype but LP geno-
type was also heterozygous at a second location not
previously described in the literature, LCTG>A 13937.
Population study
We collected DNA samples and medical surveys from 216
unrelated Hispanic individuals and 43 unrelated Amer-
indians. The survey information is summarised in table 3.
The two groups were similar in age, with a higher
representation of females among the Amerindians. The
Amerindian cohort reported a higher frequency of
intolerance to ingesting dairy products and recurring
diarrhoea, while both groups reported recurring
abdominal bloating with equal frequency.
The genotype and allele frequencies for the
LCTC>T 13910 SNP are shown in table 3. As was found
in the study group of 51 Chilean patients with suspected
lactose intolerance, there was complete concordance
between the genotypes of the LCTC>T 13910 and
LCTG>A 22018 SNPs in each individual (data not
shown). The cohort of Amerindian individuals was in
HardyeWeinberg (HW) equilibrium (ﬁgure 2), but we
observed a slightly higher-than-expected frequency of
the T 13910 allele in the Hispanic population (deviation
from HW equilibrium, p<0.05). Interestingly, this
Table 1 Clinical and genetic characteristics of 51 Chilean patients having undergone a hydrogen breath test for suspected
lactose non-persistence
Hydrogen breath
test-positive (n[29)
Hydrogen breath
test-negative (n[22) p Value
Female gender (%) 82.7 86.3 NS
Age (years) 36619 32612 NS
N8 reporting gastrointestinal symptoms after lactose load 24 (82%) 6 (27%) <0.001
N8 reporting family history of irritable bowel syndrome 22 (76%) 8 (36%) <0.001
Lactase-13910 CC genotype 26 (89.6%) 1 (4.5%) <0.001
Lactase-13910 CT/TT genotype 3 (10.3%) 21 (95.5%) <0.001
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in other mixed ethnicity groups.
33 5The prevalence of
the ancestral LCT-13910CC genotype (the LNP geno-
type) was 56.9%, signiﬁcantly lower than the prevalence
of this genotype among the Amerindian individuals
(88.3%). In turn, 41.7% of the Hispanics were LCT-
13910CT genotype, compared with only 11.7% of the
Amerindians. The LCT-13910TT genotype was found in
only three Hispanic subjects. Allele frequencies for the
LCTC>T 13910 SNP were signiﬁcantly different between
the two groups, with the T 13910 allele being very
infrequent in Amerindians.
For the 216 Hispanic individuals studied, we were able
to gather clinical and genetic data (table 3). Individuals
with the LNP LCT-13910CC genotype were three times
more likely to report intolerance to the ingestion of
dairy products and recurring diarrhoea than those with
LP genotypes (LCT-13910CT or LCT-13910TT). For 112
of these individuals, we collected complete nutritional
information. The consumption of dairy products was in
general very low, equivalent to an average of 30 l of fresh
milk per year per person. However, the group of indi-
viduals with an LP genotype had a 38% higher
consumption of dairy products than the group of indi-
viduals with the LNP genotype (38.4 l667 l vs 27.7 l640 l
milk/year, respectively), although this difference was
not statistically signiﬁcant.
DISCUSSION
The normal physiological decrease in lactase (LCT)
production in the mammalian intestine following
weaning is known as LNP and results in the inability to
digest the milk sugar, lactose, which can cause gastroin-
testinal symptoms after ingestion of dairy products. The
condition of lactase persistence (LP), found only in
humans, allows the individual to continue to ingest and
absorb lactose into adulthood. In European populations
and some Afro-Arab pastoral groups, the LP condition
has been shown to be due to SNPs found 13.9 kb
upstream of the LCT gene and actually located within
the 13th intron of the MCM6 gene. One of these SNPs,
LCTC>T 13910 (rs4988235), appeared approximately
10000 years ago in the human history and spread
progressively from Northern Europe to the rest of the
world owing to population migration and mixing,
thereby increasing the state of LP in different popula-
tions.
2 The original populations of the Americas and
Asia were likely LNP. There is no evidence of the exis-
tence of American variants that might have generated
the LP state in the pre-Columbian era.
25The T 13910
allele, which leads to the LP state, was likely introduced
to the Americas by the migration of European carriers of
this variant approximately 500 years ago and spread
rapidly in the descending admixed Hispanic (Mestizo)
populations of contemporary America, as is shown in
this study as well as others.
53 6
Our study of a representative population of Chile
consisting of Hispanic and Amerindian individuals
showed the prevalence of the LNP state (LCT-13910CC
genotype) to be 57% and 88%, respectively. It is inter-
esting to note that this observed genotypic frequency is
very similar to the Amerindian admixture index esti-
mated by us in these same populations based on the
distribution of ABO blood groups.
28 This suggests that
the analysis of the LCTC>T 13910 SNP in Latin Amer-
ican populations can be a good indicator of the degree
of Amerindian or Caucasian inheritance.
Table 2 Correlation of the hydrogen breath test in
comparison with lactase C>T 13910 genotype in 51 Chilean
patients
Sensitivity 96.3%
Speciﬁcity 87.5%
Predictive value-positive 89.7%
Predictive value-negative 95.5%
Likelihood ratio-positive 7.7
Likelihood ratio-negative 0.04
Figure 2 De Finetti diagram for the lactase C>T 13910 single
nucleotide polymorphism in Hispanic (black dotted line) and
Amerindian (blue dotted line) populations. The diagram shows
genotype and allele frequencies. The frequencies of
homozygous genotypes are plotted on the left and right
diagonal axes, the frequencies of heterozygous genotypes are
plotted on the vertical axis, and the allele frequencies are
depicted by the interaction of the vertical dotted lines with the
bottom perpendicular (allele 1¼C 13910). The genotype
frequencies plot on the parabola in the diagram, indicating that
the Amerindians, but not the Hispanics, are in
HardyeWeinberg equilibrium (HardyeWeinberg parabola).
The diagram was plotted using the software package
developed by TM Strom and TF Wienker (http://ihg.gsf.de/
cgi-bin/hw/hwal.pl).
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European lactase genotype determines lactase phenotype in Chilean populationIn all Chilean patients genotyped in this study, the
LCTG>A 22018 SNP genotype correlated completely with
the genotype found for the LCTC>T 13910 SNP,
a ﬁnding reported in many studies. This phenomenon
can be explained by the fact that both SNPs are located
within a highly conserved block of linkage disequilibrium
of at least 500 kb and likely co-segregate.
2 5
According to HW equilibrium, in the group of 216
unrelated Hispanic individuals we observed a higher-
than-expected frequency of the T 13910 allele. While this
could be explained by selection bias or by a higher
frequency of LP in the Spanish population that founded
the Chilean colony, it could also be reﬂective of positive
selection for LP allele carriers, as has been suggested for
decades.
37e39 Any evolutionary advantage conferred by
the T 13910 allele may or may not be related to the
consumption of dairy products. Indeed, it was reported
that this allele confers protection not only against bone
fractures
40 41 but also against colon cancer.
42
The validity of using LCTC>T 13910 SNP genotyping
for diagnosis of the LNP or LP state was evaluated in the
group of 51 Chilean patients with suspected LNP. The
HBT showed a high positive and negative predictive
value, sensitivity and speciﬁcity compared with genetic
testing (table 2). These results are similar to those
recently reported by other groups
10 24 34 43 and conﬁrm
the utility of the analysis of this SNP as a clinical test for
the diagnosis of LP/LNP in the adult Chilean popula-
tion. Only three patients (10.3%) with malabsorption of
lactose shown by HBT were genetically LP (LCT-
13910CT genotype). It was not possible to recall these
three patients to carry out complementary studies to rule
out other causes of lactose malabsorptiondfor example,
intestinal parasitic infections such as Giardiasis, sero-
negative celiac disease or other conditions, as has been
shown in other recent studies.
43 Interestingly, one of
these patients was also heterozygous at an additional
SNP not previously described, LCTG>A 13937.
2 We
do not know if this new variant can explain the
phenotypeegenotype discordance.
A recent study showed a high prevalence of celiac
illness among patients with an initial diagnosis of LNP,
suggesting that lactose intolerance can be the ﬁrst
manifestation of celiac illness; the authors recommend
considering the existence of celiac illness in all patients
with LNP before recommending a lactose-free diet for
life.
44 In our study of 51 patients with clinical suspicion
of lactose intolerance, only one with LNP conﬁrmed
by HBP and SNP genotyping had positive anti-tTG
(2% of the total) suggesting the coexistence of both
conditions.
One 16-year-old patient had negative HBT yet had the
LNP genotype. It is possible that this patient has not yet
manifested the LNP phenotype and still maintains
sufﬁcient levels of intestinal lactase to digest a 25 g load.
The age at which the LNP state is initiated varies
among different populations and ethnic groups, starting
as early as 1e8 years in black and Asian populations,
and much later (20 years) in northern European
populations.
10 45e47 The age of initiation of the LNP
state in Chilean individuals remains unknown.
Among the 51 Chilean patients with positive HBT and
the LCT-13910CC genotype, signiﬁcantly more report
having relatives with functional digestive disorders than
their HBT-negative counterparts, suggesting that the
condition of LNP could be in part responsible for
digestive symptoms. In our complete clinical, nutritional
and genetic study of 112 Hispanic individuals, those with
the LCT-13910CC genotype were signiﬁcantly more
likely to self-report lactose intolerance, despite very low
(30 l milk/person/year) consumption of dairy products.
This level is well below the WHO recommended level of
240 l of milk/person/year. Reasons for the low level of
consumption are likely due to multiple causes including
cost, preference and societal habits which are likely
inﬂuenced by the existence of a high prevalence of LNP
and lactose intolerant state within this population. It has
been reported that the allele frequencies of the
LCTC>T 13910 SNP within a population correlate with
the tendency of that population to consume dairy
products and ingest calcium.
48e50 Both this study and
one other
51 show that the effective consumption of
dairy products and calcium in Chile remains below
international recommendations.
Table 3 General characteristics, self-reported gastrointestinal symptoms related to dairy ingestion and lactase (LCT)
C>T 13910 single nucleotide polymorphism genotype and allele frequencies in a population of Hispanic and Amerindian
individuals
Hispanics n[216 Amerindians n[43 p Value
Women (%) 46 65 0.02
Age (years) 50612 54615 NS
N8 self-reporting lactose intolerance 44 (20.4%) 19 (44.1%) 0.001
N8 reporting diarrhoea 15 (7%) 16 (37.2%) <0.001
N8 reporting bloating 77 (35.6%) 14 (32.5%) NS
LCT-13910 CC genotype 123 (56.9%) 38 (88.3%) <0.001
LCT-13910 CT genotype 90 (41.7%) 5 (11.7%) <0.001
LCT-13910 TT genotype 3 (1.4%) 0 NS
C allele frequency 77.7% 94.2% <0.001
T allele frequency 22.3% 5.8% <0.001
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European lactase genotype determines lactase phenotype in Chilean populationIn summary, the LNP state continues to be predomi-
nant in the Chilean population. Epidemiologically, this
may cause the development of digestive symptoms
affecting quality of life and leading to medical consul-
tations as well as a lower tendency to ingest dairy prod-
ucts and calcium within the adult population of the
contemporary Americas. The fact that the LNP state is an
inherited condition should be considered when devel-
oping public programmes that encourage consumption
of dairy products, and should be a stimulus for the food
industry to develop new lactose-free dairy products.
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